Fed. Circ. Remand Shows Nautilus May Have Little Impact
Law360, New York (April 27, 2015, 9:39 PM EDT) -- The Federal Circuit's remand ruling Monday that a Biosig Instruments Inc. patent asserted against Nautilus Inc. is not indefinite, the same conclusion it reached before the U.S. Supreme Court changed the indefiniteness test last year, shows that the new standard likely won't cause the spike in invalidity findings that some expected, attorneys say.
The Federal Circuit , ordered by the Supreme Court to take the new Nautilus standard into account and review its 2013 decision that Biosig Instruments Inc.'s heart rate monitor patent is not indefinite, concluded that the revised test did not change the outcome of the case. (Credit: Getty)...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!